Sign in

Abstract

The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers
Citations
34
FWCI
3.66
Field percentile
top 5%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISMannar '21Kim '21Singh '21Tchesnokova '21Dadonaite '23Bozdaganyan '21
78% semantic matchBiochemistry
D. Mannar, J. W. Saville, X. Zhu+8 more·Cell Reports·Dec 1, 2021